Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neo Química is a leading Brazilian pharmaceutical company and a core subsidiary of Hypera Pharma. Founded in 1959, it specializes in the development and production of generic and similar medicines, as well as over-the-counter (OTC) products. The company operates one of the largest pharmaceutical manufacturing facilities in Latin America, located in the Anápolis industrial district in Goiás. Neo Química maintains a dominant position in the Brazilian retail market, offering a vast portfolio that spans numerous therapeutic areas including cardiology, endocrinology, and infectious diseases. The brand is also highly visible through its significant investments in sports marketing, most notably holding the naming rights to the Neo Química Arena in São Paulo.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neo Química.